Clinical Surveillance Tool for End of Life Care

(HOMR Trial)

Enrolling by invitation at 12 trial locations
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Ottawa Hospital Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a tool designed to help doctors identify patients who may need special care as they near the end of their lives. The goal is to enhance how hospitals recognize and address the needs of patients with serious illnesses. Conducted at 12 hospitals, the trial evaluates whether the Clinical Surveillance Tool improves patient care. Eligible participants include patients newly admitted to participating hospital units who can understand and speak English well enough to take part in assessments. As an unphased trial, this study allows patients to contribute to advancements in hospital care for those with serious illnesses.

What prior data suggests that this clinical surveillance tool is safe for end-of-life care?

Research has shown that the Clinical Surveillance Tool is safe and easy to use. In earlier studies, both patients and healthcare providers found it practical and acceptable. The tool successfully influenced doctors' actions in hospitals, demonstrating its effectiveness in real-life situations.

This tool doesn't involve any medication or physical treatment. Instead, it uses data to identify patients who might need extra care. Since it's not a drug or medical procedure, there are no reports of physical side effects. Specifically, it improved the quality of end-of-life care without causing harm.

Overall, evidence supports the tool's safety for hospital use, and it has been well-received by users.12345

Why are researchers excited about this trial?

Unlike traditional end-of-life care options that rely on medical staff assessments and standard checklists, the Clinical Surveillance Tool offers a more dynamic approach by utilizing predictive analytics to identify patients who may benefit from palliative interventions sooner. Researchers are excited about this tool because it integrates seamlessly into existing healthcare systems, providing real-time alerts and insights that can improve patient care without additional burden on healthcare providers. This innovative approach has the potential to enhance decision-making processes, ensuring patients receive compassionate and timely care tailored to their needs.

What evidence suggests that this clinical surveillance tool is effective for identifying unmet palliative needs?

Research has shown that the Clinical Surveillance Tool helps identify hospital patients at higher risk of passing away within a year. In this trial, researchers will observe participants after implementing the HOMR intervention, which uses this tool. Studies have found that many of these patients require extra care to manage symptoms and enhance their quality of life. The tool is easy to use and accepted by both patients and healthcare providers. It aids doctors in delivering better care for patients with serious illnesses by promoting timely and improved palliative care. Overall, the tool ensures patients receive the necessary support and attention during end-of-life care.16789

Are You a Good Fit for This Trial?

This trial is for newly admitted patients to certain medical units who may be in their final year of life. Participants must be able to understand and speak English well enough to answer assessment questions.

Inclusion Criteria

I can speak and understand English well enough to answer health questions.
I am a new patient in a specific unit during the study period.

Exclusion Criteria

I cannot complete certain health questionnaires due to cognitive issues or language barriers.
This criterion does not apply to me.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation

Implementation of mHOMR/HOMR-Now! application to identify patients at increased risk of death and trigger screening for unmet palliative needs

6-9 months
Ongoing assessments and interventions

Follow-up

Participants are monitored for safety and effectiveness after intervention

Up to 52 weeks post-discharge
Regular follow-up visits

Continuous Improvement

Regular updates and sharing of learnings across sites to improve implementation

What Are the Treatments Tested in This Trial?

Interventions

  • Clinical Surveillance Tool

Trial Overview

The trial tests a clinical surveillance tool designed to identify hospital patients at high risk of dying within the next year, aiming to improve palliative care by recognizing unmet needs early.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: post HOMR interventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ottawa Hospital Research Institute

Lead Sponsor

Trials
585
Recruited
3,283,000+

Centre for Aging and Brain Health Innovation

Collaborator

Trials
16
Recruited
5,200+

Bruyere Research Institute

Collaborator

Trials
35
Recruited
2,024,000+

Unity Health Toronto

Collaborator

Trials
572
Recruited
470,000+

London Health Sciences Centre

Collaborator

Trials
151
Recruited
60,400+

Headwaters Health Care Centre

Collaborator

Trials
2
Recruited
3,500+

Bruyère Health Research Institute.

Collaborator

Queen's University

Collaborator

Kingston Health Sciences Centre

Collaborator

Trials
312
Recruited
112,000+

Kingston Health Sciences Centre

Collaborator

Trials
32
Recruited
34,400+

Citations

Clinical Surveillance Tool to Screen for Unmet Palliative ...

Patients who were identified by the tool will also be followed over time to collect outcome and impact measures to see if their end-of-life care was affected

What gets measured in palliative care? A review and ... - PMC

We conducted an extensive review of policy documents to identify international best practice in the use of routine data in palliative care.

The Use of Person-Centered Outcome Measures to ...

The aim was to synthesize evidence on the use of person-centered outcome measures to facilitate integrated palliative care for older people.

Use of an automated prospective clinical surveillance tool to drive ...

We developed an accurate and reliable mortality prediction tool that automatically identifies patients in hospital at elevated risk of death in the coming year.

Automated Prospective Clinical Surveillance for Inpatients ...

Most were admitted with a frailty condition (227, 56.8%), followed by chronic organ failure (94, 23.5%) and cancer (80, 20%). At Site 1 (integrated notification) ...

Quality indicators and patient outcome measures for palliative ...

The objective of this systematic review is to assess the QIs and POMs used to evaluate palliative care service on aggregated and individual levels.

End-of-life care quality measures: beyond place of death

Clinical end-of-life care outcome metrics can assess care quality well, especially those which combine several metrics to provide holistic overall assessment;

Measuring experience of care in end of life care: An overview

This paper gives an overview of measuring experience in end of life care and available resources. The underpinning principle is to use measurement/data to ...

Clinical Practice Guidelines for Quality Palliative Care

These guidelines reflect the best available data and information. End-of-life discussions, goal attainment, and distress at the end of life: Predictors and ...